Human-Resource-Development for the future provision of Clinical Pharmaceutical Services.

Area of Science:

• Pharmaceutical Sciences
• Healthcare Management
• Health Services Research

Background:

• Limited resources necessitate prioritization of Clinical Pharmaceutical Services (CPS) in hospital settings.
• Developing a systematic approach for pharmaceutical staff development is crucial for effective CPS implementation.
• Existing methods for resource allocation in CPS require objective and quantifiable strategies.

Purpose of the Study:

• To present an objectifiable method for planning the development of Clinical Pharmaceutical Services (CPS) and pharmaceutical staff.
• To introduce a Human Resource Development (HRD) score to guide resource allocation and staff planning.
• To identify specific CPS categories that require increased or decreased resource allocation.

Main Methods:

• A Human Resource Development (HRD) score was designed: HRD = P - ([I+F]/2), where P is prioritization, I is intensity, and F is frequency of CPS.
• Scores for P, I, and F ranged from 0 (minimum) to 4 (maximum).
• Estimated future development (ΔHRD) was calculated by multiplying the HRD score by the number of pharmaceutical staff positions (n) for each CPS, using ΔHRD = HRD * n.

Main Results:

• The top 5 CPS categories for increased pharmaceutical staff development included 'Interfaces/Closed-loop concepts' (ΔHRD: +7.400) and 'Progress-management/Interdisciplinary ward-rounds' (ΔHRD: +2.000).
• Categories identified for potential resource decrease to support other CPS included 'Indication-related drug analysis' (ΔHRD: -0.250) and 'Oncology consultations' (ΔHRD: -0.275).
• The HRD score and ΔHRD calculations were performed for 155 out of 162 CPS.

Conclusions:

• A weighted Human Resource Development Score, informed by expert panel assessments, provides a quantifiable basis for proposing pharmaceutical staff development in CPS.
• The developed HRD score facilitates objective decision-making for resource allocation within hospital pharmaceutical services.
• This approach enables strategic planning to optimize the implementation and expansion of essential Clinical Pharmaceutical Services.